MKI67 and central nervous system cancer: In all ADC parameters for differentiating the low Ki-67 gliomas from the high Ki-67 group, the diagnostic performance of standardized rADCmin was better than that of ADCmin, and the standardized rADCmean was higher than that of ADCmean.